Literature DB >> 27217678

Primary Melanoma of Infra Temporal Fossa: A Case Report.

Rajesh Kumar Singh1, Nitin Leekha1, Bipin T Varghese2, K R Anila3.   

Abstract

This is the second case report in English literature of a primary non-cutaneous non mucosal melanoma (NCNM) originating from Infratemporal fossa (ITF). A 21 year woman who was previously treated for craniopharyngioma 14 years back with surgery and radiation, presented with left ITF swelling which after excision was histologically confirmed to be NCNM. She has been disease free till date. Therapeutic difficulties and diagnostic dilemmas in such a case are discussed. We propose the term of non cutaneous non mucosal melanoma (NCNM) for this rare entity.

Entities:  

Keywords:  Infratemporal fossa; Non cutaneous non mucosal; Primary melanoma

Year:  2015        PMID： 27217678      PMCID： PMC4856667          DOI： 10.1007/s13193-015-0396-x

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


  14 in total

1.  MALIGNANT MELANOMA OF UNKNOWN PRIMARY ORIGIN.

Authors:  T DASGUPTA; L BOWDEN; J W BERG
Journal:  Surg Gynecol Obstet       Date:  1963-09

2.  Malignant melanoma of infratemporal fossa.

Authors:  Naresh K Panda; Shakuntala Ghosh; Sandeep Mohindra; Sridhara Simhadri; Nandita Kakkar
Journal:  Otolaryngol Head Neck Surg       Date:  2007-02       Impact factor: 3.497

3.  Histological regression in primary cutaneous melanoma: recognition, prevalence and significance.

Authors:  K Blessing; K M McLaren
Journal:  Histopathology       Date:  1992-04       Impact factor: 5.087

4.  Spontaneous regression of primary malignant melanomas with regional metastases.

Authors:  J L Smith; J S Stehlin
Journal:  Cancer       Date:  1965-11       Impact factor: 6.860

5.  Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study.

Authors:  Adil Benlyazid; Juliette Thariat; Stephane Temam; Olivier Malard; Carmen Florescu; Olivier Choussy; Marc Makeieff; Gilles Poissonnet; Nicolas Penel; Christian Righini; Bruno Toussaint; Jean Lacau St Guily; Sebastien Vergez; Thomas Filleron
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-12

Review 6.  Melanoma genetics and the development of rational therapeutics.

Authors:  Yakov Chudnovsky; Paul A Khavari; Amy E Adams
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

7.  Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group.

Authors:  K K Anbari; L M Schuchter; L P Bucky; R Mick; M Synnestvedt; D Guerry; R Hamilton; A C Halpern
Journal:  Cancer       Date:  1997-05-01       Impact factor: 6.860

8.  Improved survival for stage IV melanoma from an unknown primary site.

Authors:  Chris C Lee; Mark B Faries; Leslie A Wanek; Donald L Morton
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

9.  Malignant melanoma primary in lymph node. The case of the missing link.

Authors:  B V Shenoy; L Fort; S P Benjamin
Journal:  Am J Surg Pathol       Date:  1987-02       Impact factor: 6.394

10.  Patient characteristics, treatment, and outcome of unknown primary melanoma in the United States for the years 1981 and 1987.

Authors:  C M Sutherland; J S Chmiel; S Bieligk; D E Henson; D P Winchester
Journal:  Am Surg       Date:  1996-05       Impact factor: 0.688
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.